Better Quantum Stock: D-Wave Quantum vs. Quantum Computing Inc.

D-Wave and Quantum Computing Inc. (QCi) represent two distinct quantum approaches: D-Wave (superconducting qubits) recently launched its Advantage2 4,400‑qubit system and generates most recurring revenue from its cloud Leap platform, while QCi is developing room‑temperature photonic chips with limited commercial shipments. Historical net sales: D‑Wave $7.17M (2022), $8.76M (2023), $8.83M (2024); QCi $0.14M (2022), $0.36M (2023), $0.37M (2024); 2025–2027 estimates show D‑Wave at $25.62M, $39.83M, $78.28M and QCi at $0.80M, $2.79M, $14.99M. Market caps/valuations are frothy—D‑Wave ~$10.7B (~138x 2027 revenue) and QCi ~$2.7B (~179x 2027 revenue)—and the author favors D‑Wave as the less speculative choice despite high downside risk from lofty multiples.

Analysis

MARKET STRUCTURE: D-Wave (QBTS) benefits most from near-term commercial quantum demand because it already sells cloud services (Leap) and $20–$40M Advantage2 systems; QCi (QUBT) is a pre-revenue foundry story with 2024 sales of $0.37M versus QBTS $8.8M, so channel partners, cryogenic suppliers, and systems integrators win if QBTS scales. Competitive dynamics favor incumbents with customer access — QBTS can monetize recurring cloud revenue while QUBT faces device-level physics limits (photon loss) that cap market share unless solved within 2–4 years.

RISK ASSESSMENT: Tail risks include a failed photonics scale-up (QUBT) or QBTS dilution after spending on Advantage2 deployment; both trade at frothy 2027 P/S of ~138x (QBTS) and ~179x (QUBT), implying sensitivity to any 30–50% revenue shortfall. Near-term (days–weeks) reaction will be driven by press or funding news; short-term (3–12 months) by quarterly revenue cadence and any capital raises; long-term (2–5 years) by system adoption and demonstrated TCO benefits vs classical/accelerator alternatives. Hidden dependency: government/defense contracts could rapidly re-rate revenues but also bring export/regulatory constraints.

TRADE IMPLICATIONS: Tactical trades should be small and event-driven: favor QBTS on disciplined pullbacks (see decisions). Use long-dated options to express view without full equity exposure — buy 9–18 month puts on QUBT to hedge downside or buy QBTS LEAP calls on >30% correction. Cross-asset: a quantum selloff will raise idiosyncratic small-cap credit spreads, lift implied vol in tech options, and be a risk-off catalyst for low-quality tech names; hedge with increased cash or IG bond exposure.

CONTRARIAN ANGLES: Consensus underestimates service revenue optionality from QBTS Leap — recurring ARR could double faster than system sales if partnerships accelerate, making current 138x P/S less absurd if 2027 ARR target >$200M. Conversely, QUBT's valuation assumes flawless foundry scale; that’s a 2–4 year binary event and likely overvalued today — a 50–70% downside is plausible absent meaningful design-win cadence. Historic parallel: early cloud infra winners (AWS vs. smaller rivals) shows platform + recurring revenue outperforms one-off hardware sales over a cycle.

Key Decisions for Investors

• Establish a tactical long in QBTS sized 1–2% of portfolio equity on a >30% intraday pullback from current levels or if market cap falls toward ~$6–7B (implied P/S ~80x on 2027 est.); add another 1% if QBTS reports sequential Leap ARR growth >30% in a quarter.
• Avoid outright long QUBT equity; instead buy 9–18 month put spreads (e.g., 1x2 ratio) sized 0.5–1% notional to capture downside if QUBT fails to show commercial foundry orders within 6–12 months or if quarterly revenue < $1M.
• Execute a dollar-neutral pair trade: long $1 of QBTS vs short $1 of QUBT (size 0.5–1% each) to express relative preference for platform/revenue stability; rebalance if QBTS:QUBT spread closes by 40% or either company issues equity.
• Use options to manage entry: sell OTM 12-month QBTS puts for a target net credit if willing to own at a 30% lower basis, and cap downside with a protective buy at a -30% stop or if cash runway disclosed <12 months post-quarter.
• Monitor three binary catalysts over next 6–12 months before scaling positions: (1) QBTS Advantage2 system orders announced (>=2 public sales), (2) QUBT published design wins/foundry throughput rising to >10k chips/month, (3) any dilutive capital raise — reduce exposure if any occur.